Zymeworks Delaware Inc. Contracts & Agreements
33 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (8)
- Human Resources (10)
- Uncategorized (2)
- Sales Agreement, dated August 2, 2024, by and between Zymeworks Inc. and TD Securities (USA) LLC (Filed With SEC on August 2, 2024)
- Amended and Restated Stock Option and Equity Compensation Plan of the Company (and forms of agreements thereunder) and UK Sub-Plan to the Amended and Restated Stock Option and... (Filed With SEC on August 1, 2024)
- Amended and Restated Inducement Stock Option and Equity Compensation Plan (and forms of award agreements thereunder) (Filed With SEC on July 25, 2024)
- Employment Agreement between Zymeworks Biopharmaceuticals Inc. and Leone Patterson, dated July 19, 2024 (Filed With SEC on July 25, 2024)
- Separation Agreement and Release by and between Zymeworks BC Inc. and Christopher Astle, dated April 3, 2024 (Filed With SEC on April 4, 2024)
- Letter, dated January 5, 2024, from Zymeworks Inc. to Jeffrey Smith (Filed With SEC on March 6, 2024)
- Description of Capital Stock (Filed With SEC on March 6, 2024)
- Employment Agreement by and between Zymeworks Pharmaceuticals Limited and Jeffrey Smith, dated January 3, 2023 (Filed With SEC on March 6, 2024)
- Inducement Stock Option and Equity Compensation Plan of the Company (and forms of agreements thereunder) (Filed With SEC on March 6, 2024)
- Amended and Restated Stock Option and Equity Compensation Plan of the Company (and forms of agreements thereunder) and UK Sub-Plan to the Amended and Restated Stock Option and... (Filed With SEC on March 6, 2024)
- Amendment #2 to Employment Agreement, dated as of January 3, 2024, by and among Kenneth Galbraith and Zymeworks BC Inc (Filed With SEC on January 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on December 26, 2023)
- Registration Rights Agreement, dated December 23, 2023, by and among the Company and the Purchasers (Filed With SEC on December 26, 2023)
- Securities Purchase Agreement, dated December 23, 2023, by and among the Company and the Purchasers (Filed With SEC on December 26, 2023)
- Amended and Restated Stock Option and Equity Compensation Plan of the Company (Filed With SEC on November 7, 2023)
- Termination Agreement by and between Zymeworks BC Inc. and BeiGene, Ltd., dated September 18, 2023 (Filed With SEC on September 21, 2023)
- Third Amendment License and Collaboration Agreement by and between Zymeworks BC Inc. and BeiGene, Ltd., dated September 18, 2023 (Filed With SEC on September 21, 2023)
- Amendment No. 1 to Stock and Asset Purchase Agreement, dated May 15, 2023, by and between Zymeworks BC Inc., Zymeworks Biopharmaceuticals Inc., Zymeworks Zanidatamab Inc., and Jazz (Filed With SEC on August 10, 2023)
- Stock and Asset Purchase Agreement, dated April 25, 2023, by and between Zymeworks BC Inc., Zymeworks Biopharmaceuticals Inc., Zymeworks Zanidatamab Inc., and Jazz... (Filed With SEC on August 10, 2023)
- Amended and Restated Employment Agreement by and between Zymeworks BC Inc., the Company and Paul Moore, dated July 14, 2023 (Filed With SEC on August 10, 2023)
- Separation Agreement and Release by and between Zymeworks BC Inc. and Neil Klompas, dated May 17, 2023 (Filed With SEC on May 18, 2023)
- Amended and Restated License and Collaboration Agreement, dated May 15, 2023, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on May 16, 2023)
- Termination and License Agreement by and between Zymeworks BC Inc. and Daiichi Sankyo Co., Ltd., effective as of February 28, 2023 (Filed With SEC on May 8, 2023)
- License and Collaboration Agreement, dated October 18, 2022, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on March 7, 2023)
- Executive Incentive Compensation Plan (Filed With SEC on March 7, 2023)
- Separation and Release Agreement by and betwe (Filed With SEC on March 7, 2023)
- Description of Capital Stock (Filed With SEC on March 7, 2023)
- Amendment to Employment Agreement, dated as of December 30, 2022, by and among Kenneth Galbraith, Zymeworks BC Inc. and Zymeworks Management Inc (Filed With SEC on December 30, 2022)
- Amendment to Amended and Restated Employment Agreement, by and between Christopher Astle and Zymeworks BC Inc., dated November 17, 2022 (Filed With SEC on November 18, 2022)
- Sales Agreement, dated November 9, 2022, by and between Zymeworks Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 9, 2022)
- Amendment No. 1 to the Preferred Shares Rights Agreement, dated as of October 12, 2022, by and between Zymeworks BC Inc. and Computershare Trust Company, N.A., as rights agent (Filed With SEC on November 8, 2022)
- Open Market Sale AgreementSM, dated October 21, 2022, by and between Zymeworks Inc. and Jefferies LLC (Filed With SEC on October 21, 2022)
- Form of Indemnification Agreement between the Company and its officers and directors (Filed With SEC on July 15, 2022)
